These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4397217)

  • 1. [Drug-induced Parkinson's syndrome with cycle-dependent hyperkineses following intake of the contraceptive "Gestakliman"].
    Jörg J
    Nervenarzt; 1971 Jun; 42(6):325-9. PubMed ID: 4397217
    [No Abstract]   [Full Text] [Related]  

  • 2. [The drug-induced Parkinson's syndrome].
    Pakesch E
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):140-6. PubMed ID: 4226879
    [No Abstract]   [Full Text] [Related]  

  • 3. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug-induced Parkinson's syndrome].
    Degkwitz R
    Dtsch Med Wochenschr; 1972 Jun; 97(22):882. PubMed ID: 5032182
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced Parkinson-like syndrome.
    Va Med Mon (1918); 1968 Dec; 95(12):746-50 passim. PubMed ID: 5725399
    [No Abstract]   [Full Text] [Related]  

  • 6. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug-induced extrapyramidal symptoms].
    Janzik HH
    Dtsch Med Wochenschr; 1975 Mar; 100(11):555-7. PubMed ID: 1116439
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anatomo-clinical aspects of Parkinson's disease and parkinsonian syndromes].
    Gainotti G
    Riv Neurol; 1978; 48(2):143-92. PubMed ID: 351788
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Logemann G
    Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
    [No Abstract]   [Full Text] [Related]  

  • 10. An unusual neurological side effect of psychotropic drug treatment.
    Holden JM; Itil TM; Caraher F
    Can Psychiatr Assoc J; 1968 Dec; 13(6):565-9. PubMed ID: 4387258
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 12. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
    Brotman RK; Muzekari LH; Shanken PM
    Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of phenothiazines on dopamine metabolism and biochemistry of Parkinson's disease.
    Barbeau A
    Agressologie; 1968; 9(2):195-200. PubMed ID: 5675486
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of butaperazine in chronic schizophrenia.
    Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
    Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
    [No Abstract]   [Full Text] [Related]  

  • 15. [Persisting extrapyramidal syndrome following neuroleptic therapy].
    Nehlil J
    Rev Neurol (Paris); 1969 Apr; 120(4):270-1. PubMed ID: 5343622
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitivity to a phenothiazine (butaperazine).
    Simpson GM; Laska E
    Can Psychiatr Assoc J; 1968 Dec; 13(6):499-506. PubMed ID: 4387257
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced movement disorders.
    North RR
    Postgrad Med; 1971 Sep; 50(3):180-5. PubMed ID: 5092993
    [No Abstract]   [Full Text] [Related]  

  • 18. [Extrapyramidal hyperkineses following prior cerebral damage and long-term therapy using neuroleptics: ballistic syndrome, "hysteroid" attacks and hyopharyngeal syndrome with special reference to the clinical picture: misdiagnosis of the disorders as psychogenic and schizophrenic symptoms].
    Meyendorf R
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 105(1):165-76. PubMed ID: 4903648
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of schizophrenia and the striatum.
    Klawans HL; Goetz C; Westheimer R
    Dis Nerv Syst; 1972 Nov; 33(11):711-9. PubMed ID: 4266033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.